First Time Loading...
C

China National Accord Medicines Corp Ltd
SZSE:000028

Watchlist Manager
China National Accord Medicines Corp Ltd
SZSE:000028
Watchlist
Price: 35.13 CNY 0.92% Market Closed
Updated: Apr 30, 2024
Section:
 

Relative Value

The Relative Value of one China National Accord Medicines Corp Ltd stock under the Base Case scenario is 102.81 CNY. Compared to the current market price of 35.13 CNY, China National Accord Medicines Corp Ltd is Undervalued by 66%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
102.81 CNY
Undervaluation 66%
Relative Value
Price
C
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
69
vs Industry
88
Median 3Y
0.2
Median 5Y
0.3
Industry
2.4
Forward
0.2
More Details
10.7
P/E
P/E
Price to Earnings
10.7
vs History
82
vs Industry
40
Median 3Y
11.2
Median 5Y
13
Industry
23.2
Forward
10.7
More Details
5.8
P/OCF
P/OCF
Price to OCF
5.8
vs History
88
vs Industry
46
Median 3Y
7.8
Median 5Y
9.5
Industry
15.5
More Details
6.3
P/FCFE
P/FCFE
Price to FCFE
6.3
vs History
92
vs Industry
37
Median 3Y
8.9
Median 5Y
10.1
Industry
23.5
More Details
1
P/B
P/B
Price to Book Value
1
vs History
76
vs Industry
64
Median 3Y
1.1
Median 5Y
1.3
Industry
2.2
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
68
vs Industry
84
Median 3Y
0.3
Median 5Y
0.4
Industry
2.5
Forward
0.3
More Details
2.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.7
vs History
69
vs Industry
63
Median 3Y
2.7
Median 5Y
3.1
Industry
5.2
More Details
10.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
10.1
vs History
77
vs Industry
34
Median 3Y
10.7
Median 5Y
11.3
Industry
12.5
Forward
7.5
More Details
10.1
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
10.1
vs History
77
vs Industry
39
Median 3Y
10.7
Median 5Y
11.3
Industry
17.2
Forward
8.4
More Details
8.2
EV/OCF
EV/OCF
Enterprise Value to OCF
8.2
vs History
90
vs Industry
42
Median 3Y
11.7
Median 5Y
11
Industry
15.1
More Details
9.2
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
9.2
vs History
90
vs Industry
36
Median 3Y
14.2
Median 5Y
12.9
Industry
19.7
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
73
vs Industry
69
Median 3Y
0.8
Median 5Y
0.9
Industry
2
More Details

Multiples Across Competitors

Competitors Multiples
China National Accord Medicines Corp Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
China National Accord Medicines Corp Ltd
SZSE:000028
17B CNY 0.2 10.7 10.1 10.1
US
Mckesson Corp
NYSE:MCK
70.2B USD 0.2 23.4 16.3 18.9
US
Cencora Inc
NYSE:COR
47.7B USD 0.2 25.5 13.1 18.4
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD 0.1 20.9 11.3 15.2
US
Cardinal Health Inc
NYSE:CAH
25B USD 0.1 39.2 8.8 11.8
US
Henry Schein Inc
NASDAQ:HSIC
9B USD 0.7 21.7 11.5 15.4
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW 5.9 89.6 59.9 61.9
CN
Huadong Medicine Co Ltd
SZSE:000963
57.6B CNY 1.4 21.3 15.5 15.5
CN
Sinopharm Group Co Ltd
HKEX:1099
61.9B HKD 0.1 6.4 1.5 1.8
IT
Amplifon SpA
MIL:AMP
7.2B EUR 3.2 46.2 14.9 29.4
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
51B CNY 0.2 13.5 8 8

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.